ISLAMABAD: Turning a blind eye to the SRO of Drug Regulatory Authority of Pakistan (DRAP), pharmaceutical Companies on Sunday once again hiked the prices of life-saving drugs.
The cost was soared, on a sudden basis, from 65 per cent to 200 per cent.
It is to be noted that according to the previous SRO, the rates of these medicines were increased from 9 to 15 per cent.